RAC.AX
Price:
$1.28
Market Cap:
$222.35M
Race Oncology Limited operates as a precision oncology company in Australia. The company is developing Zantrene, a potent small molecule inhibitor of the fatso/fat mass and obesity associated protein to treat for melanoma and clear cell renal cell carcinoma, as well as acute myeloid leukaemia, breast, and ovarian cancers, which is in Phase II/III clinical trial. It has a preclinical research program with the University of Newcastle for investigating Zantrene; and strategic collaboration with the University of Wollongong to evaluate Zantrene formulations. The company was formerly known as Coronado Resources Limited and changed its name to Race Oncology Limited in July 2016. Race Oncology Limi...[Read more]
Industry
Biotechnology
IPO Date
2016-07-13
Stock Exchange
ASX
Ticker
RAC.AX
According to Race Oncology Limited’s latest financial reports and current stock price. The company's current PE Ratio is -16.00. This represents a change of 49.80% compared to the average of -10.68 of the last 4 quarters.
The mean historical PE Ratio of Race Oncology Limited over the last ten years is -21.70. The current -16.00 PE Ratio has changed 7.27% with respect to the historical average. Over the past ten years (40 quarters), RAC.AX's PE Ratio was at its highest in in the September 2014 quarter at 0. The PE Ratio was at its lowest in in the December 2014 quarter at -259.69.
Average
-21.70
Median
-19.66
Minimum
-75.81
Maximum
-1.22
Discovering the peaks and valleys of Race Oncology Limited PE Ratio, unveiling quarterly and yearly fluctuations to gain insights into the company’s financial performance and market dynamics, offering valuable data for investors and analysts alike.
Maximum Annual Increase = 1.49%
Maximum Annual PE Ratio = -1.22
Minimum Annual Increase = -93.52%
Minimum Annual PE Ratio = -75.81
Year | PE Ratio | Change |
---|---|---|
2024 | -21.66 | 8.75% |
2023 | -19.92 | -25.35% |
2022 | -26.69 | -64.80% |
2021 | -75.81 | 290.73% |
2020 | -19.40 | 1.49% |
2019 | -1.22 | -45.56% |
2018 | -2.24 | -21.09% |
2017 | -2.84 | -93.52% |
2016 | -43.92 | 1.23% |
2015 | -3.31 | -89.50% |
The current PE Ratio of Race Oncology Limited (RAC.AX) is greater than its 3-year, greater than its 5-year, and greater than its 10-year historical averages
3-year avg
-22.76
5-year avg
-32.70
10-year avg
-21.70
Race Oncology Limited’s PE Ratio is less than Imugene Limited (-2.09), less than Incannex Healthcare Limited (-2.67), less than Paradigm Biopharmaceuticals Limited (-2.05), less than Recce Pharmaceuticals Ltd (-5.49), less than Antisense Therapeutics Limited (0),
Company | PE Ratio | Market cap |
---|---|---|
-2.09 | $319.85M | |
-2.67 | $65.07M | |
-2.05 | $163.56M | |
-5.49 | $110.14M | |
0 | $52.29M |
One of the best ways to find valuable stocks to invest in is to build a custom made screener in your Excel or Google Sheets spreadsheet. This allows you to compare thousands of companies like Race Oncology Limited using the financials and key metrics that matter to you in a single view.
The easiest way to set this up is to use the Wisesheets add-on and set your spreadsheet like this:
Covering all these metrics from financial, data, dividend data, key metrics and more you can get all the data you want for over 50+ exchanges worldwide.
Get your free trial here.
The easiest way to analyze a company like Race Oncology Limited or any others is to create a spreadsheet model that automatically retrieves all of the stock data you need.
Using Wisesheets you can set up a spreadsheet model like this with simple spreadsheet formulas. If you change the ticker you can get all of the data automatically updated for you.
Whether you need live data, historical price data, financials, dividend data, key metrics, analyst estimates, or anything else...Wisesheets has you covered.
What is the PE Ratio?
How can you use the PE Ratio?
What is Race Oncology Limited's PE Ratio?
How is the PE Ratio calculated for Race Oncology Limited (RAC.AX)?
What is the highest PE Ratio for Race Oncology Limited (RAC.AX)?
What is the 3-year average PE Ratio for Race Oncology Limited (RAC.AX)?
What is the 5-year average PE Ratio for Race Oncology Limited (RAC.AX)?
How does the current PE Ratio for Race Oncology Limited (RAC.AX) compare to its historical average?